Skip to content

SFA Therapeutics Wins US Patent for Use of Short Chain Fatty Acids in Cancer Prevention

SFA Therapeutics Wins US Patent for Use of Short Chain Fatty Acids in Cancer Prevention

Targeting Ffar2 (GPR43) and Ffar3 (GPR441) and down-regulating NF-ĸB, this patent covers our first major drug, SFA001, and provides a way of …
See all stories on this topic

Channel 4 show pranks Tory MPs in show about drugs

The fictional smartphone app was said to sell drugs with a proportion of the profits being used to support youngsters in a cartel’s ‘cocaine factory’. … illegal drugs – and supports children working for drug plantations in South America.
See all stories on this topic

Xin’s Point: US, not China, key to taming its fentanyl abuse

China already included 23 fentanyl analogs and 2 precursors – the chemical ingredients used to produce the substance – on its list of controlled …
See all stories on this topic

22nd Century Files Premarket Tobacco Application (PMTA) with the FDA

22nd Century’s proposed VLN TM cigarettes – the subject of the PMTA – are … Containing only a tiny fraction of the nicotine found in the 100 leading U.S. … from the National Institute on Drug Abuse (NIDA), the U.S. Food and Drug …
See all stories on this topic

Pear Therapeutics Presents New Data on reSET® and reSET-O™ at American Academy of …

Safety and Efficacy of reSET®Prescription Digital Therapeutic for Substance Use Disorder ” presents new statistical analysis of the 12-week, multi-site …
See all stories on this topic

Published inSubstance Abuse

Be First to Comment

Leave a Reply